IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 16.629
NA - Nord America 3.534
EU - Europa 1.705
OC - Oceania 67
AF - Africa 45
SA - Sud America 45
AN - Antartide 1
Totale 22.026
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 12.689
US - Stati Uniti d'America 3.401
HK - Hong Kong 2.259
CN - Cina 1.374
GB - Regno Unito 724
IT - Italia 315
DE - Germania 217
IN - India 134
CA - Canada 113
FI - Finlandia 74
NL - Olanda 70
AU - Australia 64
UA - Ucraina 51
JP - Giappone 41
TR - Turchia 36
ZA - Sudafrica 36
FR - Francia 34
CZ - Repubblica Ceca 32
BR - Brasile 27
ES - Italia 22
ID - Indonesia 22
PL - Polonia 20
BE - Belgio 17
EE - Estonia 17
MX - Messico 17
KR - Corea 15
CH - Svizzera 14
SE - Svezia 12
RU - Federazione Russa 11
SA - Arabia Saudita 9
LT - Lituania 8
AT - Austria 7
IL - Israele 7
TW - Taiwan 7
AR - Argentina 6
HU - Ungheria 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
EG - Egitto 5
GR - Grecia 5
PE - Perù 5
RO - Romania 5
SI - Slovenia 5
CL - Cile 4
LU - Lussemburgo 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BA - Bosnia-Erzegovina 3
HR - Croazia 3
KW - Kuwait 3
NG - Nigeria 3
PH - Filippine 3
PK - Pakistan 3
TH - Thailandia 3
VN - Vietnam 3
AM - Armenia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
DK - Danimarca 2
IE - Irlanda 2
IQ - Iraq 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
JM - Giamaica 1
JO - Giordania 1
MD - Moldavia 1
MS - Montserrat 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SL - Sierra Leone 1
TV - Tuvalu 1
YE - Yemen 1
Totale 22.026
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.241
Singapore 1.273
Ashburn 1.008
Boardman 801
Hefei 703
London 658
Shanghai 478
San Francisco 145
Los Angeles 116
Pune 102
Seattle 97
Toronto 87
Munich 74
Council Bluffs 72
Washington 66
Santa Clara 61
Rome 57
Turku 41
Amsterdam 35
Helsinki 33
Melbourne 32
New York 31
Brno 29
Tokyo 29
Naples 20
Warsaw 19
Chicago 18
Milan 18
Brooklyn 16
Canberra 16
Sydney 16
São Paulo 16
West Jordan 16
Secaucus 14
Paris 13
Boston 12
Dallas 12
Hanover 12
Hasselt 12
Mexico City 12
St Louis 12
Haikou 10
Johannesburg 9
Montreal 9
Oklahoma City 9
Riyadh 9
The Dalles 9
Hyderabad 8
Phoenix 8
Charlotte 7
Chennai 7
Guangzhou 7
Markham 7
Redmond 7
Sona 7
Stockholm 7
Bologna 6
Central 6
Frankfurt am Main 6
Manchester 6
Mong Kok 6
Palermo 6
Vienna 6
Baoding 5
Bratislava 5
Charleston 5
Florence 5
Lima 5
Ljubljana 5
Modena 5
New Taipei 5
San Pietro in Lama 5
Yeonsu-gu 5
Ankara 4
Atlanta 4
Beijing 4
Budapest 4
Crawley 4
Haifa 4
Handan 4
Lincoln 4
Luxembourg 4
Miami 4
Padova 4
Reston 4
San Ferdinando Di Puglia 4
Shijiazhuang 4
Willisau 4
Wuhan 4
Andover 3
Antwerp 3
Athens 3
Barcelona 3
Bismarck 3
Brussels 3
Centurion 3
Changsha 3
Cleveland 3
Durham 3
Ferrara di Monte Baldo 3
Totale 8.832
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 216
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 215
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 199
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 199
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 198
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 198
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 193
Early impairment of food intake in patients newly diagnosed with cancer 193
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 190
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 188
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 188
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 188
Premetastatic niche: ready for new therapeutic interventions? 187
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 187
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 187
Designing a broad-spectrum integrative approach for cancer prevention and treatment 186
A key opinion leader interview with Prof D Santini: insight into cancer research. 185
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 185
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 184
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 184
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 184
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 182
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 182
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 180
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 180
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 178
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 178
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 177
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 177
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 177
Prevention of radiotherapy-induced emesis 177
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 175
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 168
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 166
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 164
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 162
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 161
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 158
Docetaxel induced pericardial effusion 158
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 148
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 134
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 104
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 103
A giant sarcoma of the parotid gland: A case report and review of the literature 102
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 100
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 98
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 96
Anestesia e malattie non comuni 95
Colorectal carcinomas and PTEN/MMAC1 gene mutations 93
'Old' and 'new' drugs for the treatment of cancer pain 92
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 91
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 91
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 90
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 90
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 87
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 87
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 86
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 86
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 86
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 85
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 85
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 85
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 85
Biological effects of cabozantinib on bone microenvironment 85
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 85
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 84
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 84
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 83
Idiosyncratic reaction after oxaliplatin infusion 83
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 82
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 82
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 82
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 82
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 81
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 81
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 81
Atypical chronic head and neck pain: don't forget Eagle's syndrome 81
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 81
[Treatment of stage-I seminoma. Critical review] 80
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 80
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 80
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 80
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 76
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 76
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 75
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 75
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 75
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 74
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 74
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 73
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 71
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 71
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 68
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 63
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 60
Classic Kaposi Sarcoma: to treat or not to treat? 58
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 58
A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients 49
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib 49
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 49
Totale 12.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 242.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 242.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.010 0 4 5 8 73 10 15 4 42 20 23 806
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.297 52 281 95 171 239 1.039 17 154 23 59 75 92
2024/202518.581 335 274 924 147 171 511 315 63 1.959 1.581 5.758 6.543
2025/202668 68 0 0 0 0 0 0 0 0 0 0 0
Totale 22.159